TPST - What's Going On With Tempest Therapeutics Stock? | Benzinga
Tempest Therapeutics Inc (NASDAQ: TPST) shares are trading lower Thursday. The company sold shares as part of a previously announced offering after the stock soared nearly 4,000% on Wednesday.
What Happened: In an amendment to the company's prospectus supplement, Tempest Therapeutics said it sold about 1.24 million shares of its common stock for gross proceeds of approximately $7 million as of Oct. 11. There is still $93 million remaining under the company's previously announced ...